1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Attention Deficit Disorder with Hyperactivity

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Attention Deficit Disorder with Hyperactivity in 2 studies

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.

Attention Deficit Disorder with Hyperactivity: A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V)

Research

Studies (2)

Authors

Other Studies

2 other studies available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Attention Deficit Disorder with Hyperactivity